Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $38
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $49
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $42
Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Cuts Target Price to $27
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA) and Stevanato Group (STVN)
STAAR Surgical Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Oppenheimer Maintains Staar Surgical(STAA.US) With Hold Rating
A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $31 to $49
Staar Surgical Price Target Cut to $31.00/Share From $41.00 by Canaccord Genuity
STAAR Surgical Company's (NASDAQ:STAA) P/E Still Appears To Be Reasonable
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $49
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
Needham Reiterates Hold on Staar Surgical
Piper Sandler Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $40
Staar Surgical | 8-K/A: STAAR Surgical Reports Third Quarter 2024 Results
STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript Summary
STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript
STAAR Surgical GAAP EPS of $0.20 Beats by $0.19, Revenue of $88.59M Beats by $1.69M